ABSTRACT
The main mechanism of toxicity of organophosphate (OP) and carbamate (CB) insecticides is their irreversible binding and inhibition of acetylcholinestrase (AChE), encoded by ace1 (acetylcholinestrase gene 1), leading to eventual death of insects. Mutations in AChE may significantly reduce insects susceptibility to these pesticides. Bombyx mori is an important beneficial insect, and no OP- or CB-resistant strains have been generated. In this study, wild-type ace1 (wace1) and mutant ace1 (mace1) were introduced into BmN cells, confirmed by screening and identification. The expression of wace1 and mace1 in the cells was confirmed by Western blot and their expression levels were about 21-fold higher than the endogenous ace1 level. The activities of AChE in wace1 and mace1 transgenic cells were 10.6 and 20.2% higher compared to control cells, respectively. mace1 transgenic cells had higher remaining activity than wace1 transgenic cells under the treatment of physostigmine (a reversible cholinesterase inhibitor) and phoxim (an OP acaricide). The results showed that ace1 transgene can significantly improve ace1 expression, and ace1 mutation at a specific site can reduce the sensitivity to AChE inhibitors. Our study provides a new direction for the exploration of the relationship between AChE mutations and drug resistance.
Subject(s)
Acetylcholinesterase/genetics , Acetylcholinesterase/metabolism , Bombyx/enzymology , Bombyx/genetics , Gene Expression Regulation , Insect Proteins/genetics , Insect Proteins/metabolism , Animals , Bombyx/drug effects , Cell Line , Cholinesterase Inhibitors/pharmacology , Gene Expression Regulation/drug effects , Insecticides/pharmacology , Mutation , Organothiophosphorus Compounds/pharmacology , Physostigmine/pharmacology , TransfectionABSTRACT
Bombyx mori orphan G protein-coupled receptor, BNGR-A4, is the specific receptor of B. mori neuropeptide F (BmNPFR, neuropeptide F designated NPF). BmNPFR binds specifically and efficiently to B. mori neuropeptides BmNPF1a and BmNPF1b, which activates the ERK1/2 signaling pathway to regulate B. mori food intake and growth. Titanium dioxide nanoparticles (TiO2 NPs) can promote B. mori growth. However, whether the mechanisms of TiO2 NPs' effects are correlated with BmNPFR remains unknown. In this study, the effects of TiO2 NPs (5mg/L) feeding and BmNPFR-dsRNA injection on B. mori food intake and growth were investigated; after TiO2 NPs treatments, B. mori food intake, body weight, and cocoon shell weight were 5.82%, 4.64%, and 9.30% higher, respectively, than those of controls. The food intake, body weight, and cocoon shell weight of the BmNPFR-dsRNA injection group were reduced by 8.05%, 6.28%, and 6.98%, respectively, compared to the control. After TiO2 NPs treatment for 72h, the transcriptional levels of BmNPFR, BmNPF1a, and BmNPF1b in the midgut were 1.58, 1.43, and 1.34-folds, respectively, of those of the control, but 1.99, 2.26, and 2.19-folds, respectively, of the BmNPFR-dsRNA injection group; the phosphorylation level of MAPK was 24.03% higher than the control, while the phosphorylation level of BmNPFR-dsRNA injection group was 71.00% of control. The results indicated that TiO2 NPs affect B. mori feeding and growth through increasing the expression of BmNPFR. This study helps clarify the roles of BmNPF/BmNPFR system in TiO2 NPs' effects on B. mori feeding, growth, and development.
